Price
Target price
-
-
-
-
-
?2.81
WKN: A2PGA1 / Symbol: DTIL / Name: Precision BioSciences / Stock / Biotechnology & Medical Research / ? /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Precision BioSciences Inc Stock
Precision BioSciences Inc is currently one of the favorites of our community with 6 Buy predictions and no Sell predictions.
With a target price of 2 € there is potential for a 474.71% increase which would mean more than doubling the current price of 0.35 € for Precision BioSciences Inc.
Our community identified positive and negative aspects for Precision BioSciences Inc stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the Precision BioSciences Inc stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Precision BioSciences Inc in the next few years
Pros
?
S********** s********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Precision BioSciences Inc vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Precision BioSciences Inc | - | - | - | - | - | - | - |
Stoke Therapeutics Inc | -6.820% | - | - | - | - | - | - |
Personalis Inc | -0.750% | -0.444% | -3.170% | -38.881% | -35.385% | -92.851% | - |
Immuron | 5.360% | 5.357% | 50.318% | 50.318% | 41.317% | -52.800% | - |
Comments
Precision BioSciences, Inc. (NASDAQ: DTIL) had its price target raised by analysts at HC Wainwright to $60.00. They now have a "buy" rating on the stock.
Show more
Ratings data for DTIL provided by MarketBeat
Precision BioSciences, Inc. (NASDAQ: DTIL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.00 price target on the stock.
Show more
Ratings data for DTIL provided by MarketBeat
Precision BioSciences, Inc. (NASDAQ: DTIL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.00 price target on the stock.
Show more
Ratings data for DTIL provided by MarketBeat